Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on ctDNA-guided Treatment Decision-making for HER2-negative Metastatic Breast Cancer

NCT07394218 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT07394218
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07394218 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on ctDNA-guided Treatment Decision-making for HER2-negative Metastatic Breast Cancer
Lead sponsor
Fudan University
Phase
Phase 2
Overall status
Recruiting
Start date
December 24, 2025
Completion date
December 31, 2028
Enrollment
122 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ctdna, metastatic breast cancer ( her2 negative)